Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial

Paul Little, Michael Moore, Jo Kelly, Ian Williamson, Geraldine Leydon, Lisa McDermott, Mark Mullee, Beth Stuart, PIPS Investigators, Paul Little, Michael Moore, Jo Kelly, Ian Williamson, Geraldine Leydon, Lisa McDermott, Mark Mullee, Beth Stuart, Karen Middleton, Julie Hooper, Katherine Salisbury, Emily Edwards, Jennifer White, Adam Nicholls, Amanda Nagle, Susannah Gant, Paul Little, Michael Moore, Jo Kelly, Ian Williamson, Geraldine Leydon, Lisa McDermott, Mark Mullee, Beth Stuart, PIPS Investigators, Paul Little, Michael Moore, Jo Kelly, Ian Williamson, Geraldine Leydon, Lisa McDermott, Mark Mullee, Beth Stuart, Karen Middleton, Julie Hooper, Katherine Salisbury, Emily Edwards, Jennifer White, Adam Nicholls, Amanda Nagle, Susannah Gant

Abstract

Objective: To estimate the effectiveness of different strategies involving delayed antibiotic prescription for acute respiratory tract infections.

Design: Open, pragmatic, parallel group, factorial, randomised controlled trial.

Setting: Primary care in the United Kingdom.

Patients: 889 patients aged 3 years and over with acute respiratory tract infection, recruited between 3 March 2010 and 28 March 2012 by 53 health professionals in 25 practices.

Interventions: Patients judged not to need immediate antibiotics were randomised to undergo four strategies of delayed prescription: recontact for a prescription, post-dated prescription, collection of the prescription, and be given the prescription (patient led). During the trial, a strategy of no antibiotic prescription was added as another randomised comparison. Analysis was intention to treat.

Main outcome measures: Mean symptom severity (0-6 scale) at days 2-4 (primary outcome), antibiotic use, and patients' beliefs in the effectiveness of antibiotic use. Secondary analysis included comparison with immediate use of antibiotics.

Results: Mean symptom severity had minimal differences between the strategies involving no prescription and delayed prescription (recontact, post-date, collection, patient led; 1.62, 1.60, 1.82, 1.68, 1.75, respectively; likelihood ratio test χ(2) 2.61, P=0.625). Duration of symptoms rated moderately bad or worse also did not differ between no prescription and delayed prescription strategies combined (median 3 days v 4 days; 4.29, P=0.368). There were modest and non-significant differences in patients very satisfied with the consultation between the randomised groups (79%, 74%, 80%, 88%, 89%, respectively; likelihood ratio test χ(2) 2.38, P=0.667), belief in antibiotics (71%, 74%, 73%, 72%, 66%; 1.62, P=0.805), or antibiotic use (26%, 37%, 37%, 33%, 39%; 4.96, P=0.292). By contrast, most patients given immediate antibiotics used antibiotics (97%) and strongly believed in them (93%), but with no benefit for symptom severity (score 1.76) or duration (median 4 days).

Conclusion: Strategies of no prescription or delayed antibiotic prescription result in fewer than 40% of patients using antibiotics, and are associated with less strong beliefs in antibiotics, and similar symptomatic outcomes to immediate prescription. If clear advice is given to patients, there is probably little to choose between the different strategies of delayed prescription.

Trial registration: ISRCTN38551726.

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the National Institute for Health Research for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4793691/bin/litp015183.f1_default.jpg
CONSORT flow diagram. Of 889 patients considered, 556 were judged not to require immediate antibiotics and were randomised. *Numbers based on general practitioner reports

References

    1. Kai J. Parents information needs and difficulties in coping with illness in pre-school children: a qualitative study. BMJ 1996;313:987-90.
    1. Cornford CS. Why patients consult when they cough: a comparison of consulting and non-consulting patients. Br J Gen Pract 1998;48:1751-4.
    1. Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC project group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87.
    1. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay A. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010;340:c2096.
    1. House of Lords. House of Lords Select Committee on Science and Technology: 7th report. Occasional Report 1998.
    1. SMAC. Standing Medical Advisory Committee (SMAC) report: the path of least resistance. Occasional Report 1998.
    1. NICE guideline development group. Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. 2008. .
    1. Spurling G, Del Mar C, Dooley L, Foxlee R. Delayed antibiotics for symptoms and complications of respiratory infections. Cochrane Database Syst Rev 2010;3:CD004417.
    1. Arnold S, Straus S. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005;4:CD003539.
    1. Arroll B, Kenealy T, Kerse N. Do delayed prescriptions reduce antibiotic use in respiratory tract infections? A systematic review. Br J Gen Pract 2003;53:871-7.
    1. Little P, Rumsby K, Kelly J, Watson L, Moore M, Warner G, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomised controlled trial. JAMA 2005;293:3029-35.
    1. Little PS, Gould C, Williamson I, Warner G, Gantley M, Kinmonth AL. Reattendance and complications in a randomised trial of prescribing strategies for sore throat: the medicalising effect of prescribing antibiotics. BMJ 1997;315:350-2.
    1. Little PS, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL. An open randomised trial of prescribing strategies for sore throat. BMJ 1997;314:722-7.
    1. Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J. A pragmatic randomised controlled trial of two prescribing strategies for acute otitis media. BMJ 2001;322:336-42.
    1. Watson L, Little P, Williamson I, Moore M, Warner G. Validation study of a diary for use in acute lower respiratory tract infection. Fam Pract 2001;18:553-4.
    1. Zhang J, Yu K. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280:1690-1.
    1. Little P, Stuart B, Hobbs FD, Butler CC, Hay AD, Campbell J, et al; DESCARTE investigators. Predictors of suppurative complications for acute sore throat in primary care: prospective clinical cohort study. BMJ 2013;347:f6867.
    1. Little P, Stuart B, Hobbs FD, Butler CC, Hay AD, Delaney B, et al; for the DESCARTE investigators. Antibiotic prescription strategies for acute sore throat: a prospective observational cohort study. Lancet Infect Dis 2014;14:213-9.
    1. Little P, Stuart B, Moore M, Coenen S, Butler C, Godycki-Cwirko M, et al. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 2012;13:123-9.
    1. Butler C, Hood K, Verheij T, Little P, Melbye H, Nuttall J, et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 2009;338:b2242.

Source: PubMed

3
Abonner